BR100 Increased By (0.82%)
BR30 Increased By (1%)
KSE100 Increased By (0.87%)
KSE30 Increased By (0.95%)
AGHA 6.44 Increased By ▲ 0.06 (0.94%)
BECO 4.36 Increased By ▲ 0.01 (0.23%)
BML 62.56 Increased By ▲ 0.01 (0.02%)
BOP 31.52 Increased By ▲ 0.13 (0.41%)
CNERGY 11.81 Increased By ▲ 0.08 (0.68%)
CSIL 5.78 Decreased By ▼ -0.13 (-2.2%)
FCCL 61.84 Increased By ▲ 0.13 (0.21%)
FFL 14.89 Increased By ▲ 0.10 (0.68%)
FNEL 1.30 Increased By ▲ 0.06 (4.84%)
KEL 6.36 Increased By ▲ 0.04 (0.63%)
KOSM 5.84 Decreased By ▼ -0.06 (-1.02%)
LOTCHEM 24.88 Increased By ▲ 0.19 (0.77%)
MLCF 106.22 Increased By ▲ 2.29 (2.2%)
NBP 174.21 Increased By ▲ 0.89 (0.51%)
NCPL 52.05 Increased By ▲ 0.22 (0.42%)
NPL 54.62 Increased By ▲ 0.59 (1.09%)
OGDC 319.55 Increased By ▲ 3.68 (1.17%)
PACE 9.32 Increased By ▲ 0.06 (0.65%)
PAEL 35.75 Increased By ▲ 0.17 (0.48%)
PIBTL 14.23 Increased By ▲ 0.57 (4.17%)
PPL 229.50 Increased By ▲ 3.43 (1.52%)
PRL 81.55 Increased By ▲ 1.27 (1.58%)
PTC 47.07 Increased By ▲ 0.43 (0.92%)
SSGC 23.99 Increased By ▲ 0.17 (0.71%)
TBL 9.24 No Change ▼ 0.00 (0%)
TELE 7.60 Increased By ▲ 0.05 (0.66%)
TPL 24.90 Increased By ▲ 0.36 (1.47%)
TPLP 12.95 Decreased By ▼ -0.04 (-0.31%)
TREET 26.05 Increased By ▲ 0.07 (0.27%)
TRG 53.57 Increased By ▲ 0.24 (0.45%)
World

COVAX vaccines reach more than 100 countries, despite supply hits

  • Despite being hit by reduced supply availability in March and April, and higher demand in India where much of its main jab AstraZeneca is made, it expects to deliver doses to all economies that have requested them in the first half of 2021, the GAVI vaccine alliance and World Health Organization said.
Published Updated
By

GENEVA: The COVAX vaccine facility has delivered nearly 38.4 million doses of COVID-19 vaccines to more than 100 countries and economies across six continents as of Thursday, six weeks after it began to roll out supplies, a statement said.

Despite being hit by reduced supply availability in March and April, and higher demand in India where much of its main jab AstraZeneca is made, it expects to deliver doses to all economies that have requested them in the first half of 2021, the GAVI vaccine alliance and World Health Organization said.

"According to its latest supply forecast, COVAX expects to deliver at least 2 billion doses of vaccines in 2021," it said. Its portfolio, currently relying on AstraZeneca and the Pfizer and BioNTech shots, would be diversified.

Comments

Comments are closed for this article.